FindTrial
Sign In

Comparison of two different doses of dexmedetomidine as additive to bupivacaine for controlling pain after inguinal hernia surgery

Comparison of two different doses of dexmedetomidine as adjuvant to 0.25% bupivacaine for surgical wound infiltration for post operative pain following inguinal hernia repair under sub-arachnoid block

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/11/022153
Enrollment
40
Registered
2019-11-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N998- Other intraoperative and postprocedural complications and disorders of genitourinary system

Interventions

Intervention1: Dexmedetomidine as adjuvant to local anaesthesia for post operative pain: Dexmedetomidine will be used as an adjuvant to local anaesthesia in inguinal hernia surgery in two different do

Sponsors

University College of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Consenting male patients scheduled for inguinal hernia repair under sub-arachnoid block. 2.Aged between 20 to 60 years. 3.Having American Society of Anaesthesiology physical status 1 or 2.

Exclusion criteria

Exclusion criteria: 1.Patients with history of cardiac disease or hypertension. 2.Patients with history of hepato-renal diseases. 3.Patients with history of respiratory diseases. 4.Patients with history of diabetes mellitus, hyperthyroidism/hypothyroidism

Design outcomes

Primary

MeasureTime frame
first analgesic requestTimepoint: from post operative period till next 24 hours—

Secondary

MeasureTime frame
Incidence of PONV Timepoint: 24 hours;Post operative pain scoreTimepoint: 24 hours;Side effects Timepoint: 24 hours;Total dose of rescue analgesic required Timepoint: 24hours—

Countries

India

Contacts

Public ContactDr Lakshay Manchanda

University College of Medical Sciences and Guru Tegh Bahadur Hospital

mahendramohit@yahoo.com9868399709

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026